Mixed medullary thyroid cancer and follicular cancer

被引:3
作者
Yaturu, Subhashini [1 ]
Fontenot, Justin
Rowland, Tania [2 ]
机构
[1] Stratton VA Med Ctr, Sect Endocrinol & Metab, 113 Holland Ave, Albany, NY 12208 USA
[2] Overton Brooks VA Med Ctr, LSUHSC, Dept Pathol, Shreveport, LA 71101 USA
来源
AMERICAN JOURNAL OF CASE REPORTS | 2011年 / 12卷
关键词
medullary thyroid cancer; follicular thyroid cancer; mixed thyroid cancer;
D O I
10.12659/AJCR.881371
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To report a rare case of mixed medullary thyroid cancer and follicular cancer. Case Report: Sixty year old male was referred for an incidental thyroid nodule on carotid ultrasound, confirmed to be 1.1 cm mixed cyst on CT scan and a cold nodule on thyroid scan and 1.7 cm complex thyroid mass with intra-nodular vascularity, central calcification and an irregular posterior border on thyroid US. No evidence of thyroid dysfunction, compressive symptoms or radiation exposure. FNA of the nodule showed a follicular lesion. Calcitonin and CEA were elevated at 584 pg/L and 15.0 ng/mL respectively. Total thyroidectomy with central neck dissection done revealed a 1.7 cm medullary thyroid cancer with microscopic invasion into the surrounding thyroid tissue. Ipsilateral level VI node was positive for medullary thyroid cancer. Four weeks post-op Ultra sound neck and thyroid bed showed two right-sided lymph nodes less than 1 cm, both adjacent to the carotid arteries and US guided FNA was attempted with insufficient material. Given the soft-tissue invasion and the persistence of lymph nodes the patient had extensive bilateral neck dissection. One of forty lymph nodes at ipsilateral node was positive with an area of medullary thyroid cancer with an adjacent area of follicular thyroid epithelial differentiation. Conclusions: This is the first reported case in the English literature of an area of follicular thyroid differentiation in a lymph node adjacent to a metastatic focus of medullary thyroid cancer in a patient without an identified primary follicular thyroid cancer.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 50 条
  • [21] Surgical management of sporadic medullary thyroid cancer
    Noullet, S.
    Tresallet, C.
    Godiris-Petit, G.
    Hoang, C.
    Leenhardt, L.
    Menegaux, F.
    JOURNAL OF VISCERAL SURGERY, 2011, 148 (04) : E244 - E249
  • [22] How I treat medullary thyroid cancer
    Kiesewetter, B.
    Riss, P.
    Scheuba, C.
    Raderer, M.
    ESMO OPEN, 2021, 6 (03)
  • [23] Vandetanib and the management of advanced medullary thyroid cancer
    Campbell, Michael J.
    Seib, Carolyn D.
    Gosnell, Jessica
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (01) : 39 - 43
  • [24] Nodular Graves' disease with medullary thyroid cancer
    Khan, Shoukat Hussain
    Rather, Tanveer Ahmed
    Makhdoomi, Rumana
    Malik, Dharmender
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 30 (04): : 341 - 344
  • [25] Advances in the management of hereditary medullary thyroid cancer
    Machens, A
    Ukkat, J
    Brauckhoff, M
    Gimm, O
    Dralle, H
    JOURNAL OF INTERNAL MEDICINE, 2005, 257 (01) : 50 - 59
  • [26] Targeted Therapy for Medullary Thyroid Cancer: A Review
    Priya, S. R.
    Dravid, Chandra Shekhar
    Digumarti, Raghunadharao
    Dandekar, Mitali
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [27] Initial surgical management of medullary thyroid cancer
    Coan, Kathryn E.
    Wang, Tracy S.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2016, 3 (03) : 259 - 266
  • [28] Cabozantinib for the Treatment of Advanced Medullary Thyroid Cancer
    Nagilla, Madhavi
    Brown, Rebecca L.
    Cohen, Ezra E. W.
    ADVANCES IN THERAPY, 2012, 29 (11) : 925 - 934
  • [29] Chapter 9: Management of Medullary Thyroid Cancer
    Deshmukh, Anuja Dhananjay
    Thomas, Anand Ebin
    Abraham, Deepak Thomas
    JOURNAL OF HEAD & NECK PHYSICIANS AND SURGEONS, 2024, 12 (SUPPL 1): : S46 - S53
  • [30] Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
    Degrauwe, Nils
    Sosa, Julie Ann
    Roman, Sanziana
    Deshpande, Hari A.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 243 - 252